Member Exclusive

Biotech Co. Submits CTA for its 2nd Trial Launching in 2015

RepliCel's autologous cell therapy, RCS-01, to be investigated as a potential treatment for aged and UV-damaged skin.

Go to the profile of Lee Buckler
Feb 23, 2015
0
0

Please sign in or register for FREE

No comments yet.